Abstract:Esterases are important biocatalysts for chemical synthesis. Several bHSL family esterases have been used to prepare (S)-2-arylpropionic acids with stronger anti-inflammatory effects via kinetic resolution. Here, we presented the discovery of key residues that controlled the enantioselectivity of bHSL family esterases to ethyl 2-arylpropionates, through careful analysis of the structural information and molecular docking. A new bHSL family esterase, Est924, was identified as a promising catalyst for kinetic resolution of racemic ethyl 2-arylpropionates with slight (R)-stereopreference. Using Est924 as the starting enzyme, protein engineering was conducted at hotspots, and the substitution of A203 was proved to enhance the enantioselectivity. The stereopreference of the mutant M1 (A203W) was inverted to ethyl (S)-2-arylpropionates, and this stereopreference was further improved in variant M3 (I202F/A203W/G208F). In addition, the optimal variant, M3, was also suitable for the resolution of ibuprofen ethyl ester and ketoprofen ethyl ester, and their efficient (S)-isomers were synthesized. Next, the whole-cell catalyst harboring M3 was used to prepare (S)-ketoprofen. (S)-ketoprofen with 86%ee was produced by whole-cell catalyst with a single freeze-thaw cycle, and the cells could be reused for at least five cycles. Our results suggested that Est924 variants could kinetically resolve economically important racemates for industrial production and further offer the opportunity for the rational design of enzyme enantioselectivity. Moreover, it is an economical process to prepare optically pure (S)-ketoprofen and (S)-naproxen by using an engineered strain harboring M3 as the catalyst.

An efficient bioprocess for enzymatic production of L-menthol with high ratio of substrate to catalyst using whole cells of recombinant E. coli.

Enzymatic Preparation of L-Menthol by a High Concentration Substrate Tolerable Esterase from a Newly Isolated Bacillus Subtilis ECU0554

Efficient Production of L-Menthol in a Two-Phase System with SDS Using an Immobilized Bacillus Subtilis Esterase

Enantioselective Hydrolysis of Dl -Menthyl Benzoate by Cell-Free Extract of Newly Isolated Acinetobacter Sp. ECU2040

Enhancing the Enantioselectivity and Catalytic Efficiency of Esterase from Bacillus subtilis for Kinetic Resolution of l-Menthol through Semirational Design

SCREENING OF STRAINS FOR ENANTIOSELECTIVE HYDROLYSIS OF RACEMIC MENTHYL BENZOATE TO PRODUCT L-MENTHOL

Enantioselective hydrolysis of dl-menthyl propionate in enzymatic preparation of l-menthol by PnbA esterase from Bacillus subtilis

Effective Asymmetric Preparation of (R)-1-[3-(trifluoromethyl)phenyl]ethanol with Recombinant E. Coli Whole Cells in an Aqueous Tween-20/natural Deep Eutectic Solvent Solution.

Iterative Multitarget Evolution Dramatically Enhances the Enantioselectivity and Catalytic Efficiency of Bacillus Subtilis Esterase Towards Bulky Benzoate Esters of Dl-Menthol

Engineering of (-)-limonene-3-hydroxylase to Enhance Its Regioselectivity for Biosynthesis of (-)-Menthol

Biocatalytic synthesis of ( S )-4-chloro-3-hydroxybutanoate ethyl ester using a recombinant whole-cell catalyst

Immobilization of Bacillus Subtilis Esterase by Simple Cross-Linking for Enzymatic Resolution of Dl-Menthyl Acetate

Enzymatic Esterification of DL‐menthol with Propionic Acid by Lipase from Candida Cylindracea

Optimization of Lipase-Catalyzed Enantioselective Esterification of (±)-Menthol in Ionic Liquid.

Development of a fermentation strategy to enhance the catalytic efficiency of recombinant Escherichia coli for l-2-aminobutyric acid production

Production of L-menthol by Immobilized Enzyme-Catalyzed Diastereoselective Transesterification

Removing the Obstacle to (-)-Menthol Biosynthesis by Building a Microbial Cell Factory of (+)-cis-Isopulegone from (-)-Limonene

Cloning and Characterization of an Enantioselective l -Menthyl Benzoate Hydrolase from Acinetobacter sp. ECU2040

Biocatalytic production of (2S,3S)-2,3-butanediol from diacetyl using whole cells of engineered Escherichia coli.

Engineered Saccharomyces cerevisiae for the De Novo Biosynthesis of (−)-Menthol

Enhanced Production of (S)-2-arylpropionic Acids by Protein Engineering and Whole-Cell Catalysis